P1 PRATIA ONCOLOGY EXPANDS RESEARCH NETWORK WITH ADDITION OF CANCER PARTNERS OF NEBRASKA

SEATTLE, Nov. 9, 2026 /PRNewswire/ -- P1 Pratia Oncology, a community-based oncology research network focused on early-phase clinical trials, announced the addition of Cancer Partners of Nebraska to its expanding network of research sites. The partnership expands P1 Pratia Oncology's reach into Nebraska and marks another step in the continued growth of its community-based early-phase research network.

The P1 network partners with established oncology practices to bring early-phase clinical trials into the communities where patients receive their care. By combining local physician relationships and patient care with dedicated early-phase research infrastructure, P1 helps practices participate in complex clinical research while keeping patients connected to the teams they already know and trust.

"We look forward to partnering with Cancer Partners of Nebraska (CPN) to bring additional innovative treatment options to patients. CPN has a strong and distinguished track record within clinical research, and we are excited to support the build-out of a focused Phase I clinical trial program," said Scott Schliebner, CEO of P1 Pratia Oncology.

Cancer Partners of Nebraska brings an established clinical research program and a longstanding commitment to providing patients with access to innovative treatment options. The practice participates in clinical trials across a range of cancer types and treatment approaches and is the first and only community oncology practice in Nebraska to become a member institution of the National Cancer Institute's clinical trials network.

The partnership brings together CPN's established research capabilities with P1's dedicated early-phase infrastructure, centralized operational and regulatory support, and expertise in conducting complex oncology trials. This collaboration will expand opportunities for eligible patients to participate in early-phase research while continuing to receive care from their established care team.

"Clinical research has long been an important part of our commitment to providing high-quality cancer care. Partnering with P1 Pratia Oncology allows us to build on that foundation by leveraging their expertise and resources to further strengthen our research program and position CPN for continued growth," said Justin Rousek, Chief Executive Officer at Cancer Partners of Nebraska.

The addition of Cancer Partners of Nebraska builds on the continued growth of the P1 network and its broader vision to expand access to early-phase clinical research in community settings.  As the network grows, more established oncology practices will have the opportunity to participate in early-phase clinical trials, giving eligible patients in their communities greater access to clinical research closer to home.

"I'm excited to join P1 and help expand CPN's research program into early-phase studies. This is an important opportunity to bring promising research closer to patients and, ultimately, help improve the care and options available to them," said Dr. Stacey Knox, Medical Oncologist at Cancer Partners of Nebraska.

P1 welcomes Cancer Partners of Nebraska to the network and looks forward to the opportunity to bring its early-phase research infrastructure and expertise to an established oncology practice with a strong commitment to clinical research.

About P1 Pratia Oncology

P1 Pratia Oncology is a community-based oncology research network focused on early-phase clinical trials.  The network partners with established community oncology practices to provide dedicated research infrastructure, operational expertise and centralized support for complex oncology studies, helping expand access to clinical research in the communities where patients receive their care.

P1 Pratia Oncology is part of Pratia, one of the largest site networks in Europe. As the world's leading oncology research network, Pratia operates 100+ research sites across eight countries, including the U.S. The network covers 85% of all therapeutic areas and executes 600+ active clinical trials annually.

About Cancer Partners of Nebraska

Cancer Partners of Nebraska is a community oncology practice dedicated to providing comprehensive, personalized cancer care and access to innovative treatment options for patients throughout Nebraska. The practice provides medical oncology, radiation oncology and clinical research services, offering eligible patients access to clinical trials across a range of cancer types and treatment approaches.

For more information about P1 Pratia Oncology, visit: p1trials.com 

For more information about Cancer Partners of Nebraska, visit: cancerpartners.com

SOURCE P1 Pratia Oncology